BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Dalos BioPharma 

421 S. Lynnhaven Road
Suite 101
Virginia Beach  Virginia  23452  U.S.A.
Phone: 757-222-9346 Fax: 757-631-2115


SEARCH JOBS
Dalos develops and sells unique topical plant-derived products for the relief of bacterial (including MRSA) and viral skin infections, as well as products for general skin care. These represent large and profitable markets with significant unmet needs. Our technology won the award at BIO 2006 as “the most innovative and commercializable technology.” All Dalos’ products have solid laboratory and clinical evidence for their activity.

Dalos focuses on sales through physicians and pharmacies, as well as direct to consumer sales via internet commerce sites. Discussions are ongoing with distributors for US and international markets. In Year Two our sales increased by 75% over Year One. We have commercialized two lead products, MersaDerm and PoxiDerm, and are preparing to launch six more. The products have been well-received by physicians and patients.

Dalos has a strong scientific advisory board, and our CEO has over 25 years of dermatology and infectious disease product development experience. We are actively seeking partnerships and distributors as well as licensing opportunities for individual indications in exchange for upfront payments and royalties. Merger or acquisition are options for the future. We are seeking up to 2 M to fund increased marketing efforts, manufacturing, and intellectual property expansion.


 Key Statistics


Email: gpekoe@dalosbio.com
Ownership: Private

Web Site: Dalos BioPharma
Employees:
Symbol: 
 



Industry
Pharmaceutical






 Company News
Currently No News Articles

//-->